1
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Brabletz T: EMT and MET in metastasis:
where are the cancer stem cells? Cancer Cell. 22:699–701. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Natalwala A, Spychal R and Tselepis C:
Epithelial-mesenchymal transition mediated tumourigenesis in the
gastrointestinal tract. World J Gastroenterol. 14:3792–3797. 2008.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
6
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar
|
7
|
Pan JJ and Yang MH: The role of
epithelial-mesenchymal transition in pancreatic cancer. J
Gastrointest Oncol. 2:151–156. 2011.PubMed/NCBI
|
8
|
Hotz B, Arndt M, Dullat S, Bhargava S,
Buhr HJ and Hotz HG: Epithelial to mesenchymal transition:
expression of the regulators snail, slug, and twist in pancreatic
cancer. Clin Cancer Res. 13:4769–4776. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Takano S, Kanai F, Jazag A, Ijichi H, Yao
J, Ogawa H, Enomoto N, Omata M and Nakao A: Smad4 is essential for
down-regulation of E-cadherin induced by TGF-βin pancreatic cancer
cell line PANC-1. J Biochem. 141:345–351. 2007.
|
10
|
Krantz SB, Shields MA, Dangi-Garimella S,
Bentrem DJ and Munshi HG: Contribution of epithelial-mesenchymal
transition to pancreatic cancer progression. Cancers. 2:2084–2097.
2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Shah AN, Summy JM, Zhang J, Park SI,
Parikh NU and Gallick GE: Development and characterization of
gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol.
14:3629–3637. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lee HJ, Kim MS, Shin JM, Park TJ, Chung HM
and Baek KH: The expression patterns of deubiquitinating enzymes,
USP22 and Usp22. Gene Expr Patterns. 6:277–284. 2006.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang XY, Pfeiffer HK, Thorne AW and
McMahon SB: USP22, an hSAGA subunit and potential cancer stem cell
marker, reverses the polycomb-catalyzed ubiquitylation of histone
H2A. Cell Cycle. 7:1522–1524. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Atanassov BS and Dent SY: USP22 regulates
cell proliferation by deubiquitinating the transcriptional
regulator FBP1. EMBO Rep. 12:924–930. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Park IK1, Qian D, Kiel M, Becker MW,
Pihalja M, Weissman IL, Morrison SJ and Clarke MF: Bmi-1 is
required for maintenance of adult self-renewing haematopoietic stem
cells. Nature. 423:302–305. 2003. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhang XY, Varthi M, Sykes SM, Phillips C,
Warzecha C, Zhu W, Wyce A, Thorne AW, Berger SL and McMahon SB: The
putative cancer stem cell marker USP22 is a subunit of the human
SAGA complex required for activated transcription and cell-cycle
progression. Mol Cell. 29:102–111. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Yang DD, Cui BB, Sun LY, Zheng HQ, Huang
Q, Tong JX and Zhang QF: The co-expression of USP22 and BMI-1 may
promote cancer progression and predict therapy failure in gastric
carcinoma. Cell Biochem Biophys. 61:703–710. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Shook D and Keller R: Mechanisms,
mechanics and function of epithelial-mesenchymal transitions in
early development. Mech Dev. 120:1351–1383. 2003. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Glinsky GV: Genomic models of metastatic
cancer: functional analysis of death-from-cancer signature genes
reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype
with altered cell cycle control and activated Polycomb Group (PcG)
protein chromatin silencing pathway. Cell Cycle. 5:1208–1216.
2006.
|
21
|
Lin Z, Yang H, Kong Q, Li J, Lee SM, Gao
B, Dong H, Wei J, Song J, Zhang DD and Fang D: USP22 antagonizes
p53 transcriptional activation by deubiquitinating Sirt1 to
suppress cell apoptosis and is required for mouse embryonic
development. Mol Cell. 46:484–494. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Bruce B, Khanna G, Ren L, Landberg G,
Jirström K, Powell C, Borczuk A, Keller ET, Wojno KJ, Meltzer P,
Baird K, McClatchey A, Bretscher A, Hewitt SM and Khanna C:
Expression of the cytoskeleton linker protein ezrin in human
cancers. Clin Exp Metastasis. 24:69–78. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hunter KW: Ezrin, a key component in tumor
metastasis. Trends Mol Med. 10:201–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Fievet BT, Gautreau A, Roy C, Del Maestro
L, Mangeat P, Louvard D and Arpin M: Phosphoinositide binding and
phosphorylation act sequentially in the activation mechanism of
ezrin. J Cell Biol. 164:653–659. 2004. View Article : Google Scholar : PubMed/NCBI
|
25
|
Thompson EW and Williams ED: EMT and MET
in carcinoma - clinical observations, regulatory pathways and new
models. Clin Exp Metastasis. 25:591–592. 2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Pujuguet P, Del Maestro L, Gautreau A,
Louvard D and Arpin M: Ezrin regulates E-cadherin-dependent
adherens junction assembly through Rac1 activation. Mol Biol Cell.
14:2181–2191. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Egeblad M and Werb Z: New functions for
the matrix metal-loproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
28
|
Duong TD and Erickson CA: MMP-2 plays an
essential role in producing epithelial-mesenchymal transformations
in the avian embryo. Dev Dyn. 229:42–53. 2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
Borghaei RC, Rawlings PL Jr, Javadi M and
Woloshin J: NF-κB binds to a polymorphic repressor element in the
MMP-3 promoter. Biochem Biophys Res Commun. 316:182–188. 2004.
|
30
|
Hanks SK and Polte TR: Signaling through
focal adhesion kinase. Bioessays. 19:137–145. 1997. View Article : Google Scholar : PubMed/NCBI
|
31
|
Schaller MD: Cellular functions of FAK
kinases: insight into molecular mechanisms and novel functions. J
Cell Sci. 123:1007–1013. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Chen Y, Wang D, Guo Z, Zhao J, Wu B, Deng
H, Zhou T, Xiang H, Gao F, Yu X, Liao J, Ward T, Xia P, Emenari C,
Ding X, Thompson W, Ma K, Zhu J, Aikhionbare F, Dou K, Cheng SY and
Yao X: Rho kinase phosphorylation promotes ezrin-mediated
metastasis in hepatocellular carcinoma. Cancer Res. 71:1721–1729.
2011. View Article : Google Scholar : PubMed/NCBI
|